From the Back Cover
The sequencing of the human genome has offered a genetic description of the entire repertoire of human genes, including a subset of disease targets. Despite this knowledge, now publically available, clinical pipelines are not yet enriched in drugs derived from targets emanating from this massive sequencing effort. A major concern for researchers in the biotechnology and pharmaceutical industries is how to choose the most likely targets for drug discovery and how to validate them.
Target Validation in Drug Discovery describes the background for the choice of target for several successful biological drugs (protein therapeutics). It offers excellent analyses of the underlying biology, the establishment of relative assays, and the translation to clinical trials of these drugs. Professionals in biotechnology and pharmaceutical drug discovery, clinical development, students, and academics in related areas of study will find this a unique reference for years to come.
. Includes detailed descriptions of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics
. Takes a look at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin
. Additional targets known as "second generation" drugs are covered and present new possible small molecule therapeutics
. Details approaches to design of orally active drugs against new disease mechanisms
. Contains contemporary technologies in drug discovery and case histories of successful drugs
具體描述
讀後感
評分
評分
評分
評分
用戶評價
相關圖書
本站所有內容均為互聯網搜索引擎提供的公開搜索信息，本站不存儲任何數據與內容，任何內容與數據均與本站無關，如有需要請聯繫相關搜索引擎包括但不限於百度，google,bing,sogou 等
© 2025 qciss.net All Rights Reserved. 小哈圖書下載中心 版权所有